Literature DB >> 9935021

Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging.

J Suzuki1, R Shimamoto, J Nishikawa, T Yamazaki, T Tsuji, F Nakamura, W S Shin, T Nakajima, T Toyo-Oka, K Ohotomo.   

Abstract

OBJECTIVES: A long-term follow-up study with nuclear magnetic resonance (NMR) imaging was undertaken to detect the morphological onset and to establish the early diagnosis in apical hypertrophic cardiomyopathy (HCM).
BACKGROUND: A spadelike configuration on left ventriculogram (LVG) is regarded as a diagnostic criterion for the classical apical HCM. There also exists a segmented hypertrophy at the apical level without indicating the spadelike features (a nonspade configuration). To detect the hypertrophied myocardium of the nonspade configuration, circumferential scrutiny of the apex is required. Although both configurations can be underlying causes of giant negative T waves, etiological relationship between the two is not clarified.
METHODS: The criteria for the spadelike configuration defined on left ventricular short-axis NMR images were as follows: (apical maximal thickness > or = 15 mm), (apical anterior thickness over basal anterior thickness > or = 1.3) and (apical posterior thickness over basal posterior thickness > or =1.3). Thirteen patients who had predominant hypertrophy (> or = 15 mm) at the apical level without the spadelike configuration underwent NMR imaging twice before and after 54+/-10 months' follow-up.
RESULTS: Apical hypertrophy that had been confined to the lateral wall in four, the anterior-lateral wall in two, and the septal-anterior wall in one developed to become circumferential hypertrophy that fulfilled the criteria for the spadelike configuration after the follow-up period.
CONCLUSIONS: The spadelike configuration can begin with the nonspade configuration and therefore, both can constitute a single disease entity of apical HCM. The early diagnosis of apical HCM can be achieved by identifying the hypertrophy frequently confined to the lateral wall at the apical level.

Entities:  

Mesh:

Year:  1999        PMID: 9935021     DOI: 10.1016/s0735-1097(98)00527-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Apical hypertrophic cardiomyopathy: diagnosed by cardiac magnetic resonance imaging.

Authors:  Mehmet Ates; Raymond Y Kwong; Martin J Lipton; Servet Tatli
Journal:  Tex Heart Inst J       Date:  2006

2.  Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Authors:  Yusuf Kasirye; Janaki Ram Manne; Narendranath Epperla; Sowjanya Bapani; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-08-04

3.  Diagnosis of apical hypertrophic cardiomyopathy using magnetic resonance imaging.

Authors:  T Ibrahim; M Schwaiger
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

4.  A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathy.

Authors:  W S Shin; M Tanaka; J Suzuki; C Hemmi; T Toyo-oka
Journal:  Am J Hum Genet       Date:  2000-10-18       Impact factor: 11.025

5.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

6.  Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy.

Authors:  Tomás F Cianciulli; María C Saccheri; Osvaldo H Masoli; Marcela F Redruello; Jorge A Lax; Luis A Morita; Juan A Gagliardi; Adriana N Dorelle; Horacio A Prezioso; Luis A Vidal
Journal:  J Nucl Cardiol       Date:  2009-01-09       Impact factor: 5.952

7.  Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy.

Authors:  Kyung-Han Lee; Hong-Joo Jang; Sang Chul Lee; Young-Hwan Kim; Eun-Jung Lee; Jung-Don Seo; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

8.  Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study.

Authors:  Masao Yamada; Kunihiko Teraoka; Masafumi Kawade; Masaharu Hirano; Akira Yamashina
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-23       Impact factor: 2.357

Review 9.  The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.

Authors:  Radwa A Noureldin; Songtao Liu; Marcelo S Nacif; Daniel P Judge; Marc K Halushka; Theodore P Abraham; Carolyn Ho; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-20       Impact factor: 5.364

10.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.

Authors:  Prathap Kanagala; Adrian S H Cheng; Anvesha Singh; John McAdam; Anna-Marie Marsh; Jayanth R Arnold; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  J Cardiovasc Magn Reson       Date:  2018-01-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.